Potential length of stay reduction with outpatient management of low risk febrile neutropenia in a regional cancer centre.
Mike Nguyen, Tate Jacobson, Babak Tamjid, Javier Torres, Arvind Sahu, Alysson Wann
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019
e18000 Background: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score can reliably identify patients with febrile neutropenia at low risk of serious complications. Outpatient management programs utilising protocol based risk stratification, daily ambulatory nursing visits, telephone follow up and early outpatient review have been successfully piloted in other Australian cancer treatment centres. Methods: We performed a retrospective review of medical records for all patients admitted at our institution with febrile neutropenia between January 1 2016 and December 31 2018. We collected information..View full abstract